Breakthroughs
for Physicians
Breakthroughs for Physicians provides timely updates on the clinical breakthroughs and scientific advances made by Northwestern Medicine physicians and Northwestern University Feinberg School of Medicine faculty members. Anchored by Northwestern Memorial Hospital and Northwestern University Feinberg School of Medicine in downtown Chicago, Northwestern Medicine is achieving medical breakthroughs through innovative research and leading-edge clinical trials while delivering world-class patient care.
Continue reading to learn about news updates, the latest research, informative articles and other medical topics. |
People with moderate to severe ulcerative colitis (UC) may soon benefit from a treatment that is well known for healing chronic wounds: hyperbaric oxygen therapy. In a recent study of patients who were hospitalized due to severe UC symptoms, hyperbaric oxygen therapy resulted in clinical improvements that helped patients avoid surgery and immunosuppressant medication. The study, led by Northwestern Medicine Gastroenterologist Parambir S. Dulai, MD, also defined the ways that hyperbaric oxygen therapy functions to improve inflammation in UC, ultimately improving quality of life for patients.
|
February 2024 Patrick M. McCarthy, MD, executive director of Northwestern Medicine Bluhm Cardiovascular Institute, talks with Kevin E. Hodges, MD, Northwestern Medicine cardiac surgeon and director of minimally invasive and robotic cardiac surgery, about the benefits of various mitral valve repair methods, including traditional and robotically assisted techniques.
|
Featuring: Momen Wahidi, MD
In this video, Momen Wahidi, MD, the Health Systems Director of Interventional Pulmonology at Northwestern Medicine and Medical Director of Canning Thoracic Institute, discusses the latest innovations in interventional pulmonology and lung cancer care.
|
January 2024 The vision of the Northwestern Medicine Department of Obstetrics and Gynecology is to serve as a global leader in obstetrics, gynecology, reproductive health and healthcare delivery through innovations in person-centered care, research and education. This report is a summary of our accomplishments over the last fiscal year, September 2022 to August 2023.
|
Amy E. Krambeck, MD, chief Endourology and Stone Disease and a professor of Urology at Northwestern Medicine, is a world leader in holmium laser enucleation of the prostate (HoLEP) for the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia (BPH).
|
Chad Mirkin, PhD, and Jeffrey Sosman, MD, both oncologists at Northwestern Medicine and members of Robert H. Lurie Comprehensive Cancer Center at Northwestern Medicine, have been added to the prestigious roster of the 2023 'Highly Cited Researchers' list, recognizing their significant impact in their respective fields over the past decade.
|
Featuring: Maciej Lesniak, MD
Northwestern Medicine investigators have identified a novel therapeutic agent that is effective in treating metastatic breast cancer and brain metastases with minimal side effects, according to a recent study published in the Journal of Clinical Investigation.
|
Join leaders in urology, medical oncology, pathology and radiology for a monthly didactic lecture series on critical topics and advances in genitourinary oncology. Lectures will take place via Microsoft Teams on the first and third Thursday of the month at 5:30pm CT.
|
Through April 6, 2025
The Breakthroughs podcast is a series of in-depth conversations with Northwestern Medicine faculty about their leading-edge research. Each episode offers a first-person narrative of new discoveries and findings that may be unknown to the medical community. The podcast format assists in translating complicated medical research on an array of medical topics to a wide physician audience. |
A Randomized Phase 2 Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Subjects Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) and FGFR Mutations or Fusions Principal Investigator: Joshua J. Meeks, MD, PhD
|
|
MISCEND Healthy Control Esophageal Registry and Biorepository Principal Investigator: Dustin A. Carlson, MD, MS
|
About Us Terms of Use Privacy Policy How to Vote for U.S. News & World Report Best Hospitals
© 2024 Northwestern Medicine® and Northwestern Memorial HealthCare. Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University |
Connect with us
breakthroughsforphysicians@nm.org International physicians, contact international@nm.org |